| Mr Neil Carson
| is a British businessman, currently Chief Executive of Johnson Matthey plc, a British multinational chemicals and precious metals company. |
| Mr Tim W Faithfull
| Mr Tim W Faithfull owns a stake in Amec Plc. |
| Mr Ian Mchoul
| Senior Independent Director/Chairman of the Audit Committee |
| Mr John Connolly
| ohn was appointed Chairman of AMEC plc in June 2011, and is also Chairman of G4S plc, the world’s leading provider of security solutions, also a FTSE100 company. John is chairman of, and an investor in a number of private companies |
| Mr Samir Yacoub Brikho
| Mr Samir Yacoub Brikho is CEO in Amec Plc |
| Mr Humphrey Richard Percy
| Mr. Humphrey Richard Percy is CEO of Kuwaiti European Holding Co. |
| Sheikh Abdullah Jaber Al Ahmed Al Sabah
| Sheikh Abdullah Jaber Al-Ahmed Al-Sabah |
| Mr Jacob Yousef Al Muzaini
| Yacob Yousef Al Muzaini |
| Mr Ijaz Rashid
| Chief Executive for Makco Group |
| Mr David Suratgar
| Mr David Suratgar is Board Member at Banque Marocaine du Commerce Exterieur and Board Member at BMCE Bank International plc. Since 2007, Suratgar is vice Chairman at Medicapital Holdings.PLC & Chairman at BMCE Bank Intl Plc. Since 2003, he is Chairman & Legal Advisor at Fortune Funds Ltd. He is also Special Advisor at the European Investment Bank & the European Commission. A member of XPV Capital Corporation, Climate Change Infrastructure Corporation, Advisor at Ch2m Hill Ltd, vice Chairman &Treasurer at Lead Intl, Chairman at TDJ, Vice President at Aluminpro Aluminium Industry Professionals Inc. Mr Suratgar was a Deputy Chairman at Morgan Grenfell & Vice Chairman at Deutsche Morgan Greenfell Intl for six years (1992-1998). He was a Senior Attorney at World Bankfor ten years (1963-1973). Mr David is a former Senior Lawyer and Special Legal Advisor at World Bank & Bmce Bank, Professor at Georgetown Univ Schl of Law, Lecturer at Oxford Univ Templeton Coll, NYU Law Schl, & Hague Academy of International Law & Special Legal Advisor at European Investment Bank. Mr David Suratgar graduated from University of Oxford & Columbia University in 1961, he also obtained his Post-Graduate Certificate from Harvard Business School. |
| Mr Anthony Hamilton
| Mr. Anthony Hamilton is a graduate of Oxford University. His early career was spent in London and New York working for the investment banks Schroders, Morgan Grenfell, and Wainright. In 1978 he joined Fox-Pitt, Kelton and was appointed Chief Executive Officer in 1994. In 1993, he became a non-executive Director of AXA Equity and Law PLC (Chairman, 1995) and in 1997 a non-executive Director of AXA UK PLC. Since September 2000, Mr. Anthony Hamilton has been non-executive Chairman of AXA UK PLC. He is also Investor Relations Executive at Vodafone Group PLC. |
| Ms Carolyn Fairbairn
| Ms Carolyn Fairbairn is Independent Director at LLOYDS Banking Group PLC. Ms Carolyn Fairbairn joined the Board on 1 June 2012 and is aged 52. Carolyn is currently a Non-Executive Director of The Vitec Group and a member of its Audit, Nominations and Remuneration Committees. In January 2012, she was appointed a trustee of Marie Curie Cancer Care. Carolyn was formerly a Non-Executive Director of the Financial Services Authority and chaired their Risk Committee, a Director of Group Development and Strategy at ITV plc and Director of Strategy and a member of the Executive Board at the BBC. She is a former partner of McKinsey & Co. and was a policy adviser in the Prime Minister's Policy Unit. Carolyn began her career as an Economist at the World Bank. |
| Ms Irene Dorner
| Ms Irene M Dorner is a board member at Rolls Royce PLC since July 2015. She joined HSBC in 1986. A Group Managing Director since 1 February 2013. Chairman of HSBC Bank USA, National Association and HSBC USA Inc.; President and Chief Executive Officer of HSBC North America Inc. Former HSBC appointments include: Chairman of HSBC Amanah Malaysia Berhad and HSBC Amanah Takaful (Malaysia) Sendirian Berhad; Deputy Chairman and Chief Executive Officer of HSBC Bank Malaysia Berhad; Chief Operating Officer, Treasury and Capital Markets; General Manager of Marketing, General Manager of Human Resources; and General Manager of Premier and Wealth Management, HSBC Bank plc. Ms. Dorner graduated from St Anne’s College Oxford with MA in Jurisprudence and is an Honorary Fellow of the College. |
| Mr Alan Davy
| Mr. Alan Davy is Group Operations Director at British American Tobacco PLC from 1 March 2013. |
| Mr Giovanni Giordano
| Giovanni Giordano (46) Group Human Resources Director. Group Human Resources Director since June 2011. Joined the Group and appointed to the Management Board in June 2011; an international human resources career with wide experience in senior roles at Procter & Gamble and Ferrero, where he was Chief Corporate Officer. |
| Mr Richard Tubb
| Dr Richard Tubb Non-Executive Director at British American Tobacco PLC. Non-Executive Director since 28 January 2013,. Brigadier General (retired), US Air Force; White House Physician Emeritus; member of the Board of Reference for Project Rescue and the Travel Medicine Advisory Board of Shoreland, Inc; advisory position at Lonsdale; and independent consultant for the Boston Consulting Group. White House Physician from 1995 to 2009, including Physician to the President of the United States from 2002 until retirement in 2009; Clinical Assistant Professor at the Uniformed Services University; various medical positions in the US Air Force. Awarded his Doctor of Medicine in 1985. |
| Mr Richard Burrows
| Mr Richard Burrows is Chairman of British American Tobacco PLC. Richard Burrows, He has been a Director since September 2009 and Chairman since November 2009 at British American Tobacco PLC and serves as Chairman of the Nominations Committee. Richards executive career has been with Irish Distillers, where he was Chief Executive from 1978-2000 and at Pernod Ricard, where he was Co-Chief Executive from 2000-2005, based in Paris. His current non-executive roles include Rentokil Initial and Carlsberg. He was Governor of the Bank of Ireland from 2005 until 2009. Richard is a member of the Trilateral Commission which fosters closer co-operation among democratic industrialised nations and has also served as President of the Irish Business and Employers Confederation, Chairman of the National Development Corporation and Chairman of the Scotch Whisky Association. |
| Mr Kieran Poynter
| Mr Kieran Poynter is Non Executive Director at British American Tobacco PLC. He also serves as a member of the Corporate Social Responsibility and Nominations Committees. He is a Non-Executive Director of International Consolidated Airlines Group S.A., Nomura International PLC, F&C Asset Management PLC and The Royal Automobile Club Limited and has served on the Presidents Committee of the Confederation of British Industry. Kieran, a chartered accountant, retired as Chairman and Senior Partner of PricewaterhouseCoopers in 2008 after 37 years with the firm during which time he lead the successful integration of Price Waterhouse and Coopers & Lybrand following their merger in 1998. |
| Graham Chipchase
| Mr Graham Chipchase is the Chief Executive of global consumer packaging company, Rexam PLC. He was appointed to the position in 2010 after previous service at Rexam as Group Director, Plastic Packaging (2005-2009) and Group Finance Director (2003-2005). Prior to joining Rexam, he was Finance Director of Aerospace Services at global engineering group, GKN plc, from 2001 to 2003. After starting his career with Coopers & Lybrand Deloitte, he held a number of finance roles in the industrial gases company, The BOC Group plc (now part of The Linde Group) (1990-2001). He is a Fellow of the Institute of Chartered Accountants in England and Wales and holds an MA (Hons) in chemistry from Oriel College, Oxford. Ms Graham Chipchase also serves as Non-Executive Director at AstraZeneca PLC. |
| Mr Pascal Soriot
| Mr Pascal Soriot was appointed as a Director and as CEO in October. From 2010 to September 2012, he served as Chief Operating Officer of Roche AG's pharmaceuticals division. Prior to that, he was CEO of Genentech, a biologics business, and led its successful merger with Roche. He joined the pharmaceutical industry in 1986 and has worked in senior management roles throughout the world in a number of major companies since then. He alse serves as Executive Director and Chief Executive Officer at AstraZeneca a significant breadth of experience in both established and emerging markets, strength of strategic thinking, a successful track record of managing change and putting strategy into operation, as well as the ability to lead a diverse organisation having lived in Australia, Japan, the US and Europe. He is a doctor of veterinary medicine (École Nationale Vétérinaire d'Alfort, Maisons-Alfort) and holds an MBA from L'Institut Supérieur des Affaires, Jouy-en-Josas. |
